TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
NERV

Minerva Neurosciences Inc

Healthcare · Biotechnology

3.30$ +1.5% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Cash Flow

All figures per share in USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow NERV
Line item 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-0.40 -0.95 -15.48 -8.29 -6.52 0.65 -8.65 -8.91 -6.61 -4.61 -4.62 -2.27 -2.58 -1,596.28
– – 0.01 0.01 0.00 0.00 0.00 0.03 0.03 0.02 0.00 0.00 0.00 0.64
0.26 0.29 7.73 0.75 0.91 1.06 1.69 1.88 1.90 0.98 0.77 0.30 0.18 156.83
– – 7.73 0.84 0.91 -0.92 1.69 5.31 1.90 4.67 2.16 – – –
0.04 0.17 0.43 -0.01 0.33 8.21 0.02 0.70 -8.91 0.05 -0.76 0.76 -0.04 -0.07
0.00 0.00 0.02 0.02 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
– 0.00 0.47 -6.26 4.52 -22.60 14.33 2.89 4.80 0.00 0.00 – – –
– – 0.00 0.00 0.00 2.21 – – – – – – – –
– – 22.33 10.59 5.24 0.00 0.14 0.11 2.59 – – – – –
– – 4.30 3.42 -0.40 -1.04 -0.83 – – – – – – –
0.39 1.65 22.21 13.10 19.44 9.95 -0.69 0.11 2.59 11.24 0.00 3.01 0.00 8,796.17
0.00 0.71 7.20 -1.46 17.44 -12.01 4.99 -5.91 0.77 6.63 -4.62 0.74 -2.58 7,199.88
-0.40 -0.95 -15.50 -8.29 -6.52 0.64 -8.65 -8.91 -6.61 -4.61 -4.62 -2.27 -2.58 -1,596.28

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?